ADC Therapeutics nimmt an der Jefferies London Healthcare Conference teil
06 nov. 2023 07h00 HE
|
ADC Therapeutics SA
LAUSANNE, Schweiz, Nov. 06, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) gab heute bekannt, dass Ameet Mallik, Chief Executive Officer, auf der Jefferies London Healthcare Conference am...
Global CD19 Antibody Market Set to Surpass $10 Billion by 2028: A Revolutionary Era in Immunotherapy
03 nov. 2023 07h43 HE
|
Research and Markets
Dublin, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The "Global CD19 Antibody Market and Clinical Pipeline Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The global CD19 Antibody...
ADC Therapeutics Announces Abstracts Accepted for Presentation at the 65th ASH Annual Meeting
02 nov. 2023 10h10 HE
|
ADC Therapeutics SA
Presentations to highlight clinical utility of ZYNLONTA® (loncastuximab tesirine-lpyl) as a single agent and in combination Oral presentation to include initial results of investigator-initiated...
Global Antibody Drug Conjugates Market Poised to Reach $19.8 Billion by 2028, Fueled by Increasing Cancer Prevalence and Clinical Advancements
26 oct. 2023 07h33 HE
|
Research and Markets
Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugates (ADC) Market by Product (Kadcyla, Enhertu, Padcev, Polivy), Linker Type (Cleavable, Non-Cleavable), Payload Type...
ADC Therapeutics to Host Third Quarter 2023 Financial Results Conference Call on November 7, 2023
24 oct. 2023 07h00 HE
|
ADC Therapeutics SA
LAUSANNE, Switzerland, Oct. 24, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that it will host a conference call and live webcast on Tuesday, November 7, 2023 at 8:30...
ADC Therapeutics to Participate in September Investor Conferences
05 sept. 2023 07h00 HE
|
ADC Therapeutics SA
LAUSANNE, Switzerland, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in two investor conferences in...
Antibody Drug Conjugate (ADC) Markets, 2035
24 août 2023 06h33 HE
|
Research and Markets
Dublin, Aug. 24, 2023 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market (7th Edition): Distribution by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens And Key...
Global Antibody Drug Conjugate (ADC) Forecast to 2028 - Next-Generation ADCs Spurring Growth Opportunities
22 août 2023 08h03 HE
|
Research and Markets
Dublin, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugate (ADC) Growth Opportunities, Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The report...
ADC Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
08 août 2023 07h00 HE
|
ADC Therapeutics SA
2Q 2023 ZYNLONTA®1 net sales increased 11% year-over-year; Implemented new go-to-market strategy during the quarter to support growth Operating expenses decreased 20%2 year-over-year due to portfolio...
ADC Therapeutics veranstaltet am 8. August 2023 eine Telefonkonferenz zu den Finanzergebnissen des zweiten Quartals 2023
01 août 2023 07h00 HE
|
ADC Therapeutics SA
LAUSANNE, Schweiz, Aug. 01, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) gab heute bekannt, dass es am Dienstag, den 8. August 2023, um 8:30 Uhr EDT eine Telefonkonferenz und einen...